Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2012-08-06
Original SEC Filing: Click here

---

Webplus: BSPM/20120806/8-K/2_EX-99.1/000.htm SEC Original: ex99-1.htm
BIOSTAR PHARMACEUTICALS, RECEIVES APPROVAL FROM XIANYANG SFDA TO RESTARTLES OF ITS GELPSULE DRUGS XIANYANG, China, August 3, 2012 – Biostar Pharmaceuticals, (NASDAQ GM: BSPM) (“Biostar” or “thempany”), a-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases andnditions, today announced that on July 30, 2012, after a thorough

---

---

Webplus: BSPM/20120806/8-K/1/000.htm SEC Original: biostarpharma8k080312.htm
FORM 8-K CURRENT REPORT August 3, 2012te of Report (Date of earliest event reported): BIOSTAR PHARMACEUTICALS, Maryland 001-34708 20-8747899 (State or Other Jurisdiction (Commission (I.R.S. Employer oforporation) Identification No.) No. 588 Shiji Avenue Xiangyang City, Shaanxi Province Peoples Republic of China 712046 86-029-33686638 N/A (Former name or formerdress, if changed since last report)

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 8-K, Date: 2012-08-06CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046